Overview

Join us for a special webinar with Sharon Hausman-Cohen, MD, FAAFP, ABIHM, to explore a more personalized and integrative path to understanding and treating ADHD. Dr. Hausman-Cohen will share how genomics can uncover root causes behind ADHD symptoms—and why some individuals may not respond well to standard stimulant medications. Drawing from over 25 years of experience in integrative medicine and cutting-edge work in genomic analysis, she will guide clinicians in identifying key gene variants that contribute to ADHD, and demonstrate how targeted interventions—through diet, lifestyle, supplements, and medications—can improve outcomes. Attendees will gain practical tools to support more personalized, effective care for patients with ADHD.

Learning Objectives
  • Identify 3 different gene variants that contribute to ADHD.
  • List specific ways of addressing ADHD related genomic variants using diet, lifestyle, supplements and medications.
  • Explain how a combination of gene variants might relate to being a poor ADHD medication responder.

Target Audience

This educational activity is intended for behavioral health professionals, including Psychologists, Social Workers, Counselors, and MFT’s.

Level

Introductory/Intermediate

   

Instructor

Sharon Hausman-Cohen, MD, FAAFP, ABIHM

Dr. Sharon Hausman-Cohen is the Chief Medical Officer and co-founder of IntellxxDNA.  Dr. Hausman-Cohen has been in the field of integrative medicine for over 25 years and is the co-author of many publications and textbook chapters relating to using genomics to improve outcomes in environmental medicine, mental health, cognitive decline and autism. She is proud that IntellxxDNA is being used in IRB approved studies as well as by well-respected functional medicine trained physicians across the country. She and her co-founder developed IntellxxDNA as an answer to an unmet need in the medical community; the need for an accurate, evidence-based genomics tool geared at helping physicians practice true root cause medicine, whether the patient has mental health concerns, cardiometabolic concerns, cognitive decline or medical mysteries. Dr. Hausman-Cohen received both her master’s degree and medical degree from Harvard Medical School. In addition to supervising the research for IntellxxDNA she practices at Resilient Health in Austin.